ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

7.82

-0.25 (-3.16%)

At close: Mar 30, 2026, 4:00 PM EDT

7.96

+0.14 (1.86%)

Pre-market: Mar 31, 2026, 4:39 AM EDT

ARS Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	41.32	50.82	70.97	210.52	60.06
Short-Term Investments	203.67	263.21	157.39	63.86	-
Cash & Short-Term Investments	244.99	314.02	228.36	274.38	60.06
Cash Growth	-21.98%	37.51%	-16.77%	356.82%	-84.46%
Accounts Receivable	25.35	8.18	-	-	-
Inventory	31.42	10.52	-	-	-
Other Current Assets	6.19	6.89	3.37	3.32	0.67
Total Current Assets	284.9	334.3	231.73	277.7	60.73
Net Property, Plant & Equipment	2.47	1.07	0.82	0.77	0.69
Other Intangible Assets	14.45	7.37	-	-	-
Other Long-Term Assets	2.79	3.11	0.64	2.96	0.02
Total Assets	327.65	351.15	233.19	281.44	61.45
Accounts Payable	37.95	22.84	2.15	4.93	3.11
Short-Term Debt	-	-	-	-	3.48
Current Portion of Leases	0.59	0.04	0.24	0.23	0.14
Unearned Revenue	0.61	0.56	-	0.28	1.46
Total Current Liabilities	39.15	23.44	2.39	5.44	8.19
Long-Term Debt	96.37	-	-	-	4.93
Long-Term Leases	-	-	0.04	0.25	0.48
Other Long-Term Liabilities	77.88	70.92	-	2.85	3.08
Total Long-Term Liabilities	174.25	70.92	0.04	3.11	8.49
Total Liabilities	213.39	94.36	2.43	8.55	16.68
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	408.73	379.87	362	349.41	10.98
Accumulated Other Comprehensive Income	0.13	0.22	0.05	0.41	-
Retained Earnings	-294.6	-123.31	-131.3	-76.94	-42.26
Total Common Shareholders' Equity	114.26	256.8	230.76	272.89	-31.27
Minority Interest	-	-	-	-	76.04
Shareholders' Equity	114.26	256.8	230.76	272.89	44.77
Total Liabilities & Equity	327.65	351.15	233.19	281.44	61.45
Total Debt	96.96	0.04	0.27	0.48	9.03
Net Cash (Debt)	148.02	313.98	228.09	273.9	51.03
Net Cash Growth	-52.86%	37.66%	-16.73%	436.74%	-86.66%
Net Cash Per Share	1.50	3.07	2.40	6.86	1.77
Book Value	114.26	256.8	230.76	272.89	-31.27
Book Value Per Share	1.16	2.51	2.42	6.83	-1.08
Tangible Book Value	99.81	249.43	230.76	272.89	-31.27
Tangible Book Value Per Share	1.01	2.44	2.42	6.83	-1.08

Updated Mar 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q